High expression of SLCO1B1 (OATP1B1) and SLCO1B3 (OATP1B3) has also been observed in BC, correlating with increased uptake rates of paclitaxel and potentially influencing the deposition of clinically relevant drugs. The gene discussed is SLCO1B3; the disease is breast cancer.